Peripheral T-cell non-Hodgkin's lymphoma NOS: naming of parts

[1] Streubel B(2006)Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma Leukemia 20 313-318

[2] Vinatzer U(1960)A new minute chromosome in human chronic granulocytic leukemia Science 132 1497-4027

[3] Willheim M(2005)The development of imatinib as a therapeutic agent for chronic myeloid leukemia Blood 105 4021-1007

[4] Raderer M(2002)Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course Leukemia 16 993-4258

[5] Chott A(2004)Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project Blood 103 4251-2924

[6] Nowell P(2004)A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas Blood 103 2920-1645

[7] Hungerford D(2002)Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma Am J Pathol 161 1635-1848

[8] Deininger M(2004)Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations Am J Pathol 164 1837-420

[9] Buchdunjer E(2005)Amplification of NOTCH1 and ABL1 gene loci is a frequent aberration in enteropathy-type T-cell lymphoma Virchows Arch 446 416-1837

[10] Druker BJ(2004)Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes Hum Mol Genet 13 1827-378

[1] Streubel B(2006)Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma Leukemia 20 313-318

[2] Vinatzer U(1960)A new minute chromosome in human chronic granulocytic leukemia Science 132 1497-4027

[3] Willheim M(2005)The development of imatinib as a therapeutic agent for chronic myeloid leukemia Blood 105 4021-1007

[4] Raderer M(2002)Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course Leukemia 16 993-4258

[5] Chott A(2004)Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project Blood 103 4251-2924

[6] Nowell P(2004)A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas Blood 103 2920-1645

[7] Hungerford D(2002)Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma Am J Pathol 161 1635-1848

[8] Deininger M(2004)Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations Am J Pathol 164 1837-420

[9] Buchdunjer E(2005)Amplification of NOTCH1 and ABL1 gene loci is a frequent aberration in enteropathy-type T-cell lymphoma Virchows Arch 446 416-1837

[10] Druker BJ(2004)Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes Hum Mol Genet 13 1827-378